James M. Daly, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 52,500 shares at $51.13 ($2.7M) on 2020-05-11, disclosed to the SEC on 2020-05-13.
Open-market sale of $2.7M ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.13 | 26,250 | $1.3M | 50.0% |
| 2 | $51.13 | 26,250 | $1.3M | 50.0% |
| Total | $51.13 avg | 52,500 | $2.7M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $15.9M | — | Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |